Cartesian Therapeutics (RNAC) Institutional Ownership $18.31 -0.51 (-2.71%) (As of 12/17/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cartesian Therapeutics (NASDAQ:RNAC)CurrentInstitutional OwnershipPercentage86.95%Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$367.15MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$30.50M Get RNAC Insider Trade Alerts Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RNAC Institutional Buying and Selling by Quarter Ad Porter & CompanyHiding in the Bible New documentary reveals the lost wealth-building secret hidden deep within ancient religious texts from almost every civilization… an investment one expert says is “so perfect that only God could have created it.” Watch it now to discover how this asset that you’ve likely never considered before can produce returns so safe, secure, and endless it is nothing short of miraculous.This is the untold, true story of God’s Investment. Cartesian Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC11,611$188K0.0%+208.6%0.046% 11/16/2024 Geode Capital Management LLC135,700$2.19M0.0%+2.1%0.534% 11/15/2024 Barclays PLC11,611$188K0.0%+208.6%0.046% 11/15/2024 State Street Corp157,495$2.54M0.0%+2.5%0.620% 11/15/2024 Ikarian Capital LLC52,193$841K0.1%-78.5%0.205% 11/13/2024 Great Point Partners LLC200,000$3.22M0.9%N/A0.787% Get the Latest News and Ratings for RNAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cartesian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/13/2024 BNP Paribas Financial Markets1,651$27K0.0%+122.5%0.006% 11/13/2024 FMR LLC2,851,830$45.97M0.0%+458.3%11.219% 10/23/2024 Lake Street Advisors Group LLC15,822$255K0.0%-50.0%0.074% 9/16/2024 Point72 DIFC Ltd1,725$47K0.0%N/A0.008% 9/16/2024 Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061% 9/16/2024 Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009% 8/27/2024 Logos Global Management LP90,000$2.43M0.2%N/A0.506% 8/15/2024 Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009% 8/14/2024 Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061% 8/14/2024 Point72 DIFC Ltd1,725$47K0.0%N/A0.008% 8/14/2024 Marshall Wace LLP30,038$811K0.0%N/A0.140% 8/14/2024 Logos Global Management LP90,000$2.43M0.2%N/A0.421% 8/9/2024 Renaissance Technologies LLC17,052$461K0.0%-96.9%0.096% 8/6/2024 Lake Street Advisors Group LLC31,644$855K0.0%N/A0.178% 8/1/2024 Rhumbline Advisers8,487$229K0.0%-93.5%0.048% 7/26/2024 Bank of New York Mellon Corp19,916$538K0.0%-93.7%0.112% 7/22/2024 Hall Laurie J Trustee1,759$48K0.0%-96.7%0.010% 5/17/2024 Artal Group S.A.9,136,635$5.94M0.2%N/A171.098% 5/14/2024 American International Group Inc.56,202$37K0.0%N/A1.052% 5/10/2024 Vanguard Group Inc.6,315,113$4.11M0.0%N/A118.172% 5/7/2024 SG Americas Securities LLC47,134$31K0.0%N/A0.883% 5/3/2024Delphi Financial Group Inc.660,852$430K0.3%N/A12.261% 5/1/2024 BNP Paribas Financial Markets59,125$38K0.0%N/A1.097% 4/23/2024 Hall Laurie J Trustee52,775$34K0.0%N/A0.979% (Data available from 1/1/2016 forward) RNAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RNAC shares? During the previous two years, 22 institutional investors and hedge funds held shares of Cartesian Therapeutics. The most heavily invested institutionals were FMR LLC ($45.97M), Artal Group S.A. ($5.94M), Vanguard Group Inc. ($4.11M), Great Point Partners LLC ($3.22M), State Street Corp ($2.54M), Logos Global Management LP ($2.43M), and Geode Capital Management LLC ($2.19M).Learn more on RNAC's institutional investors. What percentage of Cartesian Therapeutics stock is owned by institutional investors? 86.95% of Cartesian Therapeutics stock is owned by institutional investors. Learn more on RNAC's institutional investor holdings. Which institutional investors have been buying Cartesian Therapeutics stock? Of the 18 institutional investors that purchased Cartesian Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Artal Group S.A. ($9.14M), Vanguard Group Inc. ($6.32M), FMR LLC ($2.34M), Delphi Financial Group Inc. ($660.85K), Great Point Partners LLC ($200K), Logos Global Management LP ($180K), and BNP Paribas Financial Markets ($60.03K). How much institutional buying is happening at Cartesian Therapeutics? Institutional investors have bought a total of 19,166,864 shares in the last 24 months. This purchase volume represents approximately $367.15M in transactions. Which Cartesian Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cartesian Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($536.55K), Bank of New York Mellon Corp ($297.41K), Ikarian Capital LLC ($190.18K), Rhumbline Advisers ($121.40K), Hall Laurie J Trustee ($51.02K), and Lake Street Advisors Group LLC ($15.82K). How much institutional selling is happening at Cartesian Therapeutics? Institutional investors have sold a total of 1,212,365 shares in the last 24 months. This volume of shares sold represents approximately $30.50M in transactions. Related Companies CNTA Institutional Ownership PTGX Institutional Ownership IDYA Institutional Ownership LBPH Institutional Ownership WVE Institutional Ownership RXRX Institutional Ownership CGON Institutional Ownership APGE Institutional Ownership AKRO Institutional Ownership AMPH Institutional Ownership This page (NASDAQ:RNAC) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cartesian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNAC Stock Alerts